Diagnosing multiple drug hypersensitivity in children

Marina Atanasković-Marković, Francesco Gaeta, Marija Gavrović-Jankulović, Tanja Čirković Veličković, Rocco Luigi Valluzzi, Antonino Romano

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Multiple drug hypersensitivity (MDH) has been defined as a hypersensitivity to two or more chemically different drugs. Two types of MDH have been reported: the first one, which develops to different drugs administered simultaneously and the second type, in which sensitizations develop sequentially. In children, studies which diagnose MDH on the basis of positive allergologic tests to 2 or more chemically different drugs are lacking. Methods: We conducted a prospective study evaluating children with histories of MDH by skin tests, patch tests, serum-specific IgE assays, and drug provocation tests. Results: A MDH was diagnosed in 7 (2.5%) of the 279 children evaluated who completed the study. The responsible drugs were β-lactams (penicillins and cephalosporins) in 5 episodes, ibuprofen and anticonvulsants in 3, and erythromycin, fentanyl, methylprednisolone, and cotrimoxazole in 1. Sensitivity to 2 chemically different drugs was diagnosed in 6 children and to 3 drugs in 1 child. Two of the 7 children presented the first type of MDH, whereas 5 displayed the second one. Conclusions: MDH can occur in children, even to drugs other than antibiotics. It is crucial to evaluate children with histories of MDH using both in vivo and in vitro allergologic tests, including challenges. In fact, such approach allows the physician to confirm the diagnosis of MDH in a small percentage of children with histories of MDH, as well as to rule it out in the great majority of them.

Original languageEnglish
Pages (from-to)785-791
Number of pages7
JournalPediatric Allergy and Immunology
Volume23
Issue number8
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Drug Hypersensitivity
Pharmaceutical Preparations
Lactams
Patch Tests
Ibuprofen
Sulfamethoxazole Drug Combination Trimethoprim
Methylprednisolone
Fentanyl
Erythromycin
Cephalosporins
Skin Tests
Penicillins
Anticonvulsants
Immunoglobulin E
Hypersensitivity
Prospective Studies
Anti-Bacterial Agents
Physicians

Keywords

  • Challenges
  • Drug provocation tests
  • Multiple drug hypersensitivity
  • Patch tests
  • Skin tests

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health
  • Immunology

Cite this

Atanasković-Marković, M., Gaeta, F., Gavrović-Jankulović, M., Čirković Veličković, T., Valluzzi, R. L., & Romano, A. (2012). Diagnosing multiple drug hypersensitivity in children. Pediatric Allergy and Immunology, 23(8), 785-791. https://doi.org/10.1111/pai.12020

Diagnosing multiple drug hypersensitivity in children. / Atanasković-Marković, Marina; Gaeta, Francesco; Gavrović-Jankulović, Marija; Čirković Veličković, Tanja; Valluzzi, Rocco Luigi; Romano, Antonino.

In: Pediatric Allergy and Immunology, Vol. 23, No. 8, 12.2012, p. 785-791.

Research output: Contribution to journalArticle

Atanasković-Marković, M, Gaeta, F, Gavrović-Jankulović, M, Čirković Veličković, T, Valluzzi, RL & Romano, A 2012, 'Diagnosing multiple drug hypersensitivity in children', Pediatric Allergy and Immunology, vol. 23, no. 8, pp. 785-791. https://doi.org/10.1111/pai.12020
Atanasković-Marković M, Gaeta F, Gavrović-Jankulović M, Čirković Veličković T, Valluzzi RL, Romano A. Diagnosing multiple drug hypersensitivity in children. Pediatric Allergy and Immunology. 2012 Dec;23(8):785-791. https://doi.org/10.1111/pai.12020
Atanasković-Marković, Marina ; Gaeta, Francesco ; Gavrović-Jankulović, Marija ; Čirković Veličković, Tanja ; Valluzzi, Rocco Luigi ; Romano, Antonino. / Diagnosing multiple drug hypersensitivity in children. In: Pediatric Allergy and Immunology. 2012 ; Vol. 23, No. 8. pp. 785-791.
@article{532b2ade0a4e4213911447c2bbe42000,
title = "Diagnosing multiple drug hypersensitivity in children",
abstract = "Background: Multiple drug hypersensitivity (MDH) has been defined as a hypersensitivity to two or more chemically different drugs. Two types of MDH have been reported: the first one, which develops to different drugs administered simultaneously and the second type, in which sensitizations develop sequentially. In children, studies which diagnose MDH on the basis of positive allergologic tests to 2 or more chemically different drugs are lacking. Methods: We conducted a prospective study evaluating children with histories of MDH by skin tests, patch tests, serum-specific IgE assays, and drug provocation tests. Results: A MDH was diagnosed in 7 (2.5{\%}) of the 279 children evaluated who completed the study. The responsible drugs were β-lactams (penicillins and cephalosporins) in 5 episodes, ibuprofen and anticonvulsants in 3, and erythromycin, fentanyl, methylprednisolone, and cotrimoxazole in 1. Sensitivity to 2 chemically different drugs was diagnosed in 6 children and to 3 drugs in 1 child. Two of the 7 children presented the first type of MDH, whereas 5 displayed the second one. Conclusions: MDH can occur in children, even to drugs other than antibiotics. It is crucial to evaluate children with histories of MDH using both in vivo and in vitro allergologic tests, including challenges. In fact, such approach allows the physician to confirm the diagnosis of MDH in a small percentage of children with histories of MDH, as well as to rule it out in the great majority of them.",
keywords = "Challenges, Drug provocation tests, Multiple drug hypersensitivity, Patch tests, Skin tests",
author = "Marina Atanasković-Marković and Francesco Gaeta and Marija Gavrović-Jankulović and {Čirković Veličković}, Tanja and Valluzzi, {Rocco Luigi} and Antonino Romano",
year = "2012",
month = "12",
doi = "10.1111/pai.12020",
language = "English",
volume = "23",
pages = "785--791",
journal = "Pediatric Allergy and Immunology",
issn = "0905-6157",
publisher = "Blackwell Munksgaard",
number = "8",

}

TY - JOUR

T1 - Diagnosing multiple drug hypersensitivity in children

AU - Atanasković-Marković, Marina

AU - Gaeta, Francesco

AU - Gavrović-Jankulović, Marija

AU - Čirković Veličković, Tanja

AU - Valluzzi, Rocco Luigi

AU - Romano, Antonino

PY - 2012/12

Y1 - 2012/12

N2 - Background: Multiple drug hypersensitivity (MDH) has been defined as a hypersensitivity to two or more chemically different drugs. Two types of MDH have been reported: the first one, which develops to different drugs administered simultaneously and the second type, in which sensitizations develop sequentially. In children, studies which diagnose MDH on the basis of positive allergologic tests to 2 or more chemically different drugs are lacking. Methods: We conducted a prospective study evaluating children with histories of MDH by skin tests, patch tests, serum-specific IgE assays, and drug provocation tests. Results: A MDH was diagnosed in 7 (2.5%) of the 279 children evaluated who completed the study. The responsible drugs were β-lactams (penicillins and cephalosporins) in 5 episodes, ibuprofen and anticonvulsants in 3, and erythromycin, fentanyl, methylprednisolone, and cotrimoxazole in 1. Sensitivity to 2 chemically different drugs was diagnosed in 6 children and to 3 drugs in 1 child. Two of the 7 children presented the first type of MDH, whereas 5 displayed the second one. Conclusions: MDH can occur in children, even to drugs other than antibiotics. It is crucial to evaluate children with histories of MDH using both in vivo and in vitro allergologic tests, including challenges. In fact, such approach allows the physician to confirm the diagnosis of MDH in a small percentage of children with histories of MDH, as well as to rule it out in the great majority of them.

AB - Background: Multiple drug hypersensitivity (MDH) has been defined as a hypersensitivity to two or more chemically different drugs. Two types of MDH have been reported: the first one, which develops to different drugs administered simultaneously and the second type, in which sensitizations develop sequentially. In children, studies which diagnose MDH on the basis of positive allergologic tests to 2 or more chemically different drugs are lacking. Methods: We conducted a prospective study evaluating children with histories of MDH by skin tests, patch tests, serum-specific IgE assays, and drug provocation tests. Results: A MDH was diagnosed in 7 (2.5%) of the 279 children evaluated who completed the study. The responsible drugs were β-lactams (penicillins and cephalosporins) in 5 episodes, ibuprofen and anticonvulsants in 3, and erythromycin, fentanyl, methylprednisolone, and cotrimoxazole in 1. Sensitivity to 2 chemically different drugs was diagnosed in 6 children and to 3 drugs in 1 child. Two of the 7 children presented the first type of MDH, whereas 5 displayed the second one. Conclusions: MDH can occur in children, even to drugs other than antibiotics. It is crucial to evaluate children with histories of MDH using both in vivo and in vitro allergologic tests, including challenges. In fact, such approach allows the physician to confirm the diagnosis of MDH in a small percentage of children with histories of MDH, as well as to rule it out in the great majority of them.

KW - Challenges

KW - Drug provocation tests

KW - Multiple drug hypersensitivity

KW - Patch tests

KW - Skin tests

UR - http://www.scopus.com/inward/record.url?scp=84870517016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870517016&partnerID=8YFLogxK

U2 - 10.1111/pai.12020

DO - 10.1111/pai.12020

M3 - Article

C2 - 23194294

AN - SCOPUS:84870517016

VL - 23

SP - 785

EP - 791

JO - Pediatric Allergy and Immunology

JF - Pediatric Allergy and Immunology

SN - 0905-6157

IS - 8

ER -